Google’s Verily Unveils Health Watch for Medical Research | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Google’s Verily Unveils Health Watch for Medical Research

April 18, 2017
by Heather Landi
| Reprints

Verily Life Sciences, Alphabet’s health-focused subsidiary and formerly Google Life Sciences, unveiled last week its Verily Study Watch, a health tracking watch for use as an investigational device.

In a blog post, David He, technical lead, Tushar Parlikar, product manager and Harry Xiao, technical program manager at Verily, write that the Smart Watch represents another step in the company’s targeted efforts to “create new tools for unobtrusive biosensing.” And Verily says there is a need for the scalable collection of rich and complex datasets across clinical and observational studies.

The company says the architecture of Study Watch was tailored specifically for high quality signals and seamless usage, with consideration of the needs of observational studies, such as how continuous wear impacts a user’s experience. “These design and functionality decisions were reinforced by feedback from users, researchers, and clinicians,” the company says.

According to Verily, the Study Watch collects heart rate, electrocardiogram (ECG), electrodermal activity and inertial movements and a processor supports real-time algorithms on the device. Unlike commercial wearables, the watch only displays time and certain instructions, no other information is provided back to the user.

The company also says that because the investigational device stores health data, all data are encrypted on the device for security. The encrypted data are uploaded and processed in the cloud using Verily’s backend algorithms and machine learning tools.

Currently, there are plans for the Study Watch to be used in several observational studies conducted by Verily’s partners, including the Personalized Parkinson’s Project, a multi-year study to identify patterns in the progression of Parkinson’s disease and provide a foundation for more personalized treatments.

Also, Study Watch will be used in the forthcoming Baseline study. For that study, Verily is partnering with Duke University and Stanford Medicine to conduct a longitudinal observational study that will follow approximately 10,000 participants for four years to explore transitions between health and disease.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Survey: Infrastructure, Interoperability Key Barriers to Global HIT Development

A new survey report from Black Book Research on global healthcare IT adoption and records systems connectivity finds nations in various phases of regional electronic health record (EHR) adoption. The survey results also reveal rapidly advancing opportunities for U.S.-based and local technology vendors.

Penn Medicine Opens Up Telehealth Hub

Philadelphia-based Penn Medicine has opened its Center for Connected Care to centralize the health system’s telemedicine activities.

Roche to Pay $1.9B for Flatiron Health

Switzerland-based pharmaceutical company Roche has agreed to pay $1.9 billion to buy New York-based Flatiron Health Inc., which has both an oncology EHR and data analytics platform.

Financial Exec Survey: Interoperability Key Obstacle to Value-Based Payment Models

Momentum continues to grow for value-based care as nearly three-quarters of healthcare executives report their organizations have achieved positive financial results from value-based payment programs, to date, according to a new study from the Healthcare Financial Management Association (HFMA).

Cerner, Children's National to Help UAE Pediatric Center with Health IT

Al Jalila Children's Specialty Hospital, the only pediatric hospital in the United Arab Emirates, has entered into an agreement with Washington, D.C.-based Children's National Health System to form a health IT strategic partnership.

Telemedicine Association Names New CEO

The American Telemedicine Association (ATA) has named Ann Mond Johnson its new CEO, replacing Jon Linkous who stepped down suddenly last August after 24 years as the organization’s CEO.